Business Description
Orchestra BioMed Holdings Inc
NAICS : 541714
SIC : 2833
ISIN : US68572M1062
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 36.41 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -2.73 | |||||
Beneish M-Score | -2.27 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.7 | |||||
3-Year EBITDA Growth Rate | -37.8 | |||||
3-Year EPS without NRI Growth Rate | -35.1 | |||||
3-Year FCF Growth Rate | -18.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 24.35 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.66 | |||||
9-Day RSI | 48.35 | |||||
14-Day RSI | 49.23 | |||||
6-1 Month Momentum % | -12.43 | |||||
12-1 Month Momentum % | -1.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.23 | |||||
Quick Ratio | 4.21 | |||||
Cash Ratio | 4.13 | |||||
Days Inventory | 265.52 | |||||
Days Sales Outstanding | 12.33 | |||||
Days Payable | 7716.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.2 | |||||
Shareholder Yield % | 4.7 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 92.71 | |||||
Operating Margin % | -2270.68 | |||||
Net Margin % | -2179.34 | |||||
FCF Margin % | -1819.95 | |||||
ROE % | -97.7 | |||||
ROA % | -65.27 | |||||
ROIC % | -423.6 | |||||
ROC (Joel Greenblatt) % | -2109.39 | |||||
ROCE % | -81.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 78.19 | |||||
PB Ratio | 4.61 | |||||
Price-to-Tangible-Book | 4.61 | |||||
EV-to-EBIT | -2.46 | |||||
EV-to-EBITDA | -2.47 | |||||
EV-to-Revenue | 55.86 | |||||
EV-to-Forward-Revenue | 35.04 | |||||
EV-to-FCF | -3.07 | |||||
Price-to-Net-Current-Asset-Value | 5.41 | |||||
Price-to-Net-Cash | 5.63 | |||||
Earnings Yield (Greenblatt) % | -40.65 | |||||
FCF Yield % | -22.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Orchestra BioMed Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2.647 | ||
EPS (TTM) ($) | -1.61 | ||
Beta | 0 | ||
Volatility % | 91.68 | ||
14-Day RSI | 49.23 | ||
14-Day ATR ($) | 0.464494 | ||
20-Day SMA ($) | 5.77925 | ||
12-1 Month Momentum % | -1.29 | ||
52-Week Range ($) | 4.22 - 11.69 | ||
Shares Outstanding (Mil) | 37.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Orchestra BioMed Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Orchestra BioMed Holdings Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Orchestra BioMed Holdings Inc Frequently Asked Questions
What is Orchestra BioMed Holdings Inc(OBIO)'s stock price today?
When is next earnings date of Orchestra BioMed Holdings Inc(OBIO)?
Does Orchestra BioMed Holdings Inc(OBIO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |